DK2877183T3 - Forbedring af seksuel ophidselse, seksuallyst, orgasme og/eller nydelse efter intravaginal prasteron-(dhea)-indgivelse i kvinder som ikke lider af eller uafhængigt af dyspareuni eller øvrige symptomer på vulvo-vaginal atropi - Google Patents

Forbedring af seksuel ophidselse, seksuallyst, orgasme og/eller nydelse efter intravaginal prasteron-(dhea)-indgivelse i kvinder som ikke lider af eller uafhængigt af dyspareuni eller øvrige symptomer på vulvo-vaginal atropi Download PDF

Info

Publication number: DK2877183T3
Authority: DK; Denmark
Prior art keywords: sexual; vylovr; sylvovre; prasteron; dyspareuni
Prior art date: 2012-07-25

Application number

DK13822094.2T

Other languages

English (en)

Inventor

Fernand Labrie

Original Assignee

Endorecherche Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-07-25

Filing date

2013-07-19

Publication date

2021-03-08

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49996456&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2877183(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2013-07-19 Application filed by Endorecherche Inc filed Critical Endorecherche Inc

2021-03-08 Application granted granted Critical

2021-03-08 Publication of DK2877183T3 publication Critical patent/DK2877183T3/da

Links

FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 title 1
230000035946 sexual desire Effects 0.000 title 1
230000001568 sexual effect Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Reproductive Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Gynecology & Obstetrics (AREA)
Urology & Nephrology (AREA)
Diabetes (AREA)
Pregnancy & Childbirth (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK13822094.2T 2012-07-25 2013-07-19 Forbedring af seksuel ophidselse, seksuallyst, orgasme og/eller nydelse efter intravaginal prasteron-(dhea)-indgivelse i kvinder som ikke lider af eller uafhængigt af dyspareuni eller øvrige symptomer på vulvo-vaginal atropi DK2877183T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201261675717P	2012-07-25	2012-07-25
US13/942,977 US20140045806A1 (en)	2012-07-25	2013-07-16	Sexual arousal, sexual desire, orgasm and/or pleasure following intravaginal prasterone (dhea) administration in women not suffering or independently from dyspareunia or other symptoms of vulvo-vaginal atrophy
PCT/CA2013/000654 WO2014015416A1 (en)	2012-07-25	2013-07-19	Improvement of sexual arousal, sexual desire, orgasm and/or pleasure following intravaginal prasterone (dhea) administration in women not suffering or independently from dyspareunia or other symptoms of vulvo-vaginal atrophy

Publications (1)

Publication Number	Publication Date
DK2877183T3 true DK2877183T3 (da)	2021-03-08

Family

ID=49996456

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK13822094.2T DK2877183T3 (da)	2012-07-25	2013-07-19	Forbedring af seksuel ophidselse, seksuallyst, orgasme og/eller nydelse efter intravaginal prasteron-(dhea)-indgivelse i kvinder som ikke lider af eller uafhængigt af dyspareuni eller øvrige symptomer på vulvo-vaginal atropi

Country Status (25)

Country	Link
US (1)	US20140045806A1 (da)
EP (1)	EP2877183B1 (da)
JP (3)	JP2015522625A (da)
KR (4)	KR102258122B1 (da)
CN (2)	CN111529536A (da)
AR (1)	AR091907A1 (da)
BR (1)	BR112015001479A2 (da)
CA (2)	CA2972491C (da)
CL (1)	CL2015000169A1 (da)
DK (1)	DK2877183T3 (da)
EA (1)	EA028263B1 (da)
ES (1)	ES2848215T3 (da)
HK (1)	HK1204983A1 (da)
IL (1)	IL236868B (da)
IN (1)	IN2014DN10901A (da)
MA (1)	MA37799B2 (da)
MX (2)	MX375078B (da)
MY (1)	MY183944A (da)
NZ (2)	NZ717808A (da)
PH (1)	PH12014502790A1 (da)
SG (1)	SG11201500228UA (da)
TW (1)	TWI693070B (da)
UA (1)	UA114517C2 (da)
WO (1)	WO2014015416A1 (da)
ZA (1)	ZA201409179B (da)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020013304A1 (en) *	1997-10-28	2002-01-31	Wilson Leland F.	As-needed administration of an androgenic agent to enhance female sexual desire and responsiveness
EP1441707A1 (en) *	2001-11-09	2004-08-04	Pharmacia AB	Anti-muscarinic agent and estrogen-agonist for treating unstable or overactive bladder
US20060252734A1 (en) *	2004-09-08	2006-11-09	Woodward John R	Methods of female sexual enhancement
US8835413B2 (en) *	2004-10-20	2014-09-16	Endorecherche, Inc.	Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cGMP phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women
US8268806B2 (en) *	2007-08-10	2012-09-18	Endorecherche, Inc.	Pharmaceutical compositions
US20130231317A1 (en) *	2011-07-19	2013-09-05	Michael S. Riepl	Dhea bioadhesive controlled release gel

2013
- 2013-07-16 US US13/942,977 patent/US20140045806A1/en not_active Abandoned
- 2013-07-18 MA MA37799A patent/MA37799B2/fr unknown
- 2013-07-19 CA CA2972491A patent/CA2972491C/en not_active Expired - Fee Related
- 2013-07-19 KR KR1020207001389A patent/KR102258122B1/ko active Active
- 2013-07-19 DK DK13822094.2T patent/DK2877183T3/da active
- 2013-07-19 UA UAA201501578A patent/UA114517C2/uk unknown
- 2013-07-19 MY MYPI2015700175A patent/MY183944A/en unknown
- 2013-07-19 ES ES13822094T patent/ES2848215T3/es active Active
- 2013-07-19 BR BR112015001479A patent/BR112015001479A2/pt not_active IP Right Cessation
- 2013-07-19 SG SG11201500228UA patent/SG11201500228UA/en unknown
- 2013-07-19 KR KR20157002158A patent/KR20150033696A/ko not_active Ceased
- 2013-07-19 CA CA2879648A patent/CA2879648C/en not_active Expired - Fee Related
- 2013-07-19 CN CN202010122058.9A patent/CN111529536A/zh active Pending
- 2013-07-19 HK HK15105870.7A patent/HK1204983A1/xx unknown
- 2013-07-19 EP EP13822094.2A patent/EP2877183B1/en active Active
- 2013-07-19 NZ NZ717808A patent/NZ717808A/en not_active IP Right Cessation
- 2013-07-19 EA EA201500165A patent/EA028263B1/ru unknown
- 2013-07-19 JP JP2015523354A patent/JP2015522625A/ja active Pending
- 2013-07-19 KR KR1020177022207A patent/KR20170095399A/ko not_active Ceased
- 2013-07-19 WO PCT/CA2013/000654 patent/WO2014015416A1/en not_active Ceased
- 2013-07-19 KR KR1020217015590A patent/KR20210062746A/ko not_active Ceased
- 2013-07-19 MX MX2015001064A patent/MX375078B/es active IP Right Grant
- 2013-07-19 CN CN201380037621.0A patent/CN104540511A/zh active Pending
- 2013-07-19 NZ NZ703168A patent/NZ703168A/en not_active IP Right Cessation
- 2013-07-24 TW TW102126477A patent/TWI693070B/zh not_active IP Right Cessation
- 2013-07-25 AR ARP130102659A patent/AR091907A1/es unknown
2014
- 2014-12-12 ZA ZA2014/09179A patent/ZA201409179B/en unknown
- 2014-12-15 PH PH12014502790A patent/PH12014502790A1/en unknown
- 2014-12-19 IN IN10901DEN2014 patent/IN2014DN10901A/en unknown
2015
- 2015-01-22 IL IL236868A patent/IL236868B/en active IP Right Grant
- 2015-01-23 CL CL2015000169A patent/CL2015000169A1/es unknown
- 2015-01-23 MX MX2020009333A patent/MX2020009333A/es unknown
2016
- 2016-12-01 JP JP2016233998A patent/JP6618887B2/ja active Active
2019
- 2019-08-16 JP JP2019149357A patent/JP6893960B2/ja active Active

Also Published As

Publication number	Publication date
MA37799B2 (fr)	2021-02-26
KR20200008055A (ko)	2020-01-22
WO2014015416A9 (en)	2014-07-03
TWI693070B (zh)	2020-05-11
CN111529536A (zh)	2020-08-14
MX375078B (es)	2025-03-06
PH12014502790B1 (en)	2015-02-09
MY183944A (en)	2021-03-17
AR091907A1 (es)	2015-03-11
MX2020009333A (es)	2020-10-08
WO2014015416A1 (en)	2014-01-30
CN104540511A (zh)	2015-04-22
CA2879648C (en)	2017-10-31
UA114517C2 (uk)	2017-06-26
MA37799A1 (fr)	2016-08-31
IL236868B (en)	2020-09-30
PH12014502790A1 (en)	2015-02-09
EP2877183B1 (en)	2020-12-16
SG11201500228UA (en)	2015-02-27
KR102258122B1 (ko)	2021-05-28
ES2848215T3 (es)	2021-08-05
EP2877183A1 (en)	2015-06-03
CL2015000169A1 (es)	2015-08-07
TW201408305A (zh)	2014-03-01
US20140045806A1 (en)	2014-02-13
AU2013296091B2 (en)	2016-01-07
ZA201409179B (en)	2015-12-23
EP2877183A4 (en)	2016-03-09
KR20210062746A (ko)	2021-05-31
MX2015001064A (es)	2015-07-14
BR112015001479A2 (pt)	2017-07-04
JP6618887B2 (ja)	2019-12-11
EA201500165A1 (ru)	2015-07-30
HK1204983A1 (en)	2015-12-11
IL236868A0 (en)	2015-03-31
CA2879648A1 (en)	2014-01-30
AU2013296091A1 (en)	2015-01-22
JP2017057211A (ja)	2017-03-23
JP2019196404A (ja)	2019-11-14
CA2972491C (en)	2020-12-29
EA028263B1 (ru)	2017-10-31
JP2015522625A (ja)	2015-08-06
KR20150033696A (ko)	2015-04-01
NZ717808A (en)	2017-08-25
CA2972491A1 (en)	2014-01-30
NZ703168A (en)	2016-04-29
KR20170095399A (ko)	2017-08-22
JP6893960B2 (ja)	2021-06-23
IN2014DN10901A (da)	2015-09-11

Similar Documents

Publication	Publication Date	Title
CL2014003232A1 (es)	2015-03-13	Formulaciones y métodos para la administración vaginal de antiprogestinas.
MX373641B (es)	2020-05-04	Nanoportadores sintéticos tolerogénicos para la terapia contra alergias.
ZA201701785B (en)	2018-05-30	Use of gabaa receptor reinforcing agent in preparation of sedative and anesthetic medicament
IL244945A0 (en)	2016-05-31	Cationic lipid, lipid formulations comprising same and use thereof in the preparation of therapeutic agents for delivering to cells
EA201590215A1 (ru)	2015-06-30	Макроциклические пурины для лечения вирусных инфекций
IL239022B (en)	2020-11-30	Tetracycline topical formulations, preparation and uses thereof
SI2560653T1 (sl)	2016-08-31	Določeni aminopirimidini, sestavki le-teh in postopki za njihovo uporabo
WO2013090842A3 (en)	2013-10-10	Ophthalmic compositions comprising polyvinyl caprolactam - polyvinyl acetate - polyethylene glycol graft copolymers (soluplus)
CA144779S (en)	2012-10-24	Device for performing soft tissue massage
EP2833911A4 (en)	2016-07-13	SUB-VACCINE VACCINATING PLATFORM FOR ROBUST HUMORAL AND CELLULAR IMMUNE RESPONSES
MX383154B (es)	2025-03-13	Usos de naltrexona y bupoprion para tratar depresión mayor.
WO2013188627A3 (en)	2014-02-06	Cationic lipid vaccine compositions and methods of use
IL231901A0 (en)	2014-05-28	New compositions of pyrimethanil and their use for crop treatment
PH12014502259A1 (en)	2014-12-15	Association of beta-glucans and arabinoxylans
WO2013190509A3 (en)	2014-03-13	Preparation of intermediates of boceprevir
EA201490562A1 (ru)	2014-08-29	Способы лечения связанной с инсультом сенсорно-двигательной недостаточности с использованием аминопиридинов
DK2877183T3 (da)	2021-03-08	Forbedring af seksuel ophidselse, seksuallyst, orgasme og/eller nydelse efter intravaginal prasteron-(dhea)-indgivelse i kvinder som ikke lider af eller uafhængigt af dyspareuni eller øvrige symptomer på vulvo-vaginal atropi
DE112013005775A5 (de)	2015-08-13	Überlebenshilfe, insbesondere für Schwimmer und Wassersportler
MX390596B (es)	2025-03-19	Procedimientos y composicion para la induccion de respuesta inmunitaria.
TWD173913S (zh)	2016-02-21	健身座椅之部分（一）
刘艳君	2012	Analysis of Hollywood Movie Mulan in Post-colonialism Context
Yang et al.	2014	Study on the Upstream Effectors of NF-B/PKC/JNK and PI3K/PDK1/PP2A/eEF2Pathways for Tylophorine Elevated c-Jun Protein Level in Carcinoma Cells
Xinzhen	2013	Cybercafes in Decline
TH1501000324A (th)	2016-08-01	การปรับปรุงให้ดีขึ้นของความตื่นตัวทางเพศ, ความต้องการทางเพศ, ความเสียวสุดยอดทางเพศ และ/หรือ ความพึงพอใจ หลังการให้พราสเตอโรน (dhea) ในช่องคลอดในผู้หญิงที่ไม่มีหรือเป็นอิสระจากอาการปวดเฉียบขณะ ร่วมเพศหรืออาการอื่นๆ ของโยนีและช่องคลอดฝ่อลีบ
钟凯纹	2012	Walking in a Blur